Nanhua Bio: There are no major matters that should be disclosed but have not been disclosed.

Nanhua Bio announced that the company's stock price closed with a cumulative deviation of more than 20% over three consecutive trading days from September 22 to 24, 2026, constituting an abnormal fluctuation in the stock price. From September 17 to 24, the company's stock price rose from RMB 8.27 to RMB 13.73 over six consecutive trading days, a cumulative increase of 66.02%, showing characteristics of overheated market sentiment and irrational speculation. Upon verification, the company has no major matters that should be disclosed but have not been disclosed, and neither the controlling shareholder nor the actual controller has bought or sold the company's shares.